Table 4

Patient and disease characteristics at baseline for all patients and by testing status (tested and untested)

CharacteristicsAll patientsTestedUntestedP value

n=250n=201n=48
N%N%N%
Age at diagnosis, median (IQR)67.0 (59.0–73.0)66.0 (59.0–72.0)70.0 (61.3–75.0)0.023
Year of diagnosis0.497
 20164819.23617.91225.0
 20178032.06431.81531.3
 20187128.46130.31020.8
 20195120.44019.91122.9
BMI at diagnosis, kg/m20.534
 <18.583.252.536.3
 ≥18.5 and ≤24.910843.28642.82143.8
 ≥25.0 and ≤29.98132.46532.31633.3
 ≥304618.43818.9816.7
 Unknown72.873.5
Country of birth (self-reported)0.770
 The Netherlands19276.815476.63879.2
 Other72.863.0
 Unknown5120.44120.41020.8
Educational level* (self-reported)0.399
 Low7028.05326.41633.3
 Medium10943.69245.81735.4
 High62.442.024.2
 Unknown6526.05225.91327.1
Parity at diagnosis (self-reported)0.164
 Yes15762.813165.22654.2
 No4016.02813.91225.0
 Unknown5321.24220.91020.8
Smoking status Former smoker row 70 Tested, 15 Not tested but Total = 86 diagnosis (self-reported)0.882
 Never smoker10040.07939.32143.8
 Former smoker8634.47034.81531.3
 Current smoker218.4189.036.3
 Unknown4317.23416.9918.8
Family history of cancer at diagnosis (self-reported)0.485
 Yes13955.611557.22347.9
 No6726.85225.91531.3
 Unknown4417.63416.91020.8
WHO performance status at diagnosis0.217
 014256.811356.22960.4
 15421.64321.41122.9
 2145.6115.536.3
 331.210.524.2
 Unknown3714.83316.436.3
Frailty at diagnosis (GFI)0.533
 <4 (non-frail)11445.69145.32347.9
 ≥4 (frail)4718.83617.91122.9
 Unknown8935.67436.81429.2
Histology at diagnosis<0.001
 High-grade serous17369.215074.62245.8
 Non-high-grade serous7228.84823.92450.0
 Adenocarcinoma NOS52.031.524.2
FIGO stage at diagnosis0.018
 I/II6425.64522.41939.6
 III/IV18574.015577.12960.4
 Unknown10.410.5
  • One patient who rejected germline test was not included in analysis by testing status.

  • *Educational levels were defined as follows: low=primary or secondary education or less, medium=vocational education, high=university or higher education.

  • BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; GFI, Groningen Frailty Index; IQR, Interquartile range; NOS, not otherwise specified.